Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

Recruiting now

Conditions studied: Solid Tumor

In brief

This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.

Key facts

Study ID

NCT02806388

Run by

National Cancer Centre, Singapore

People needed

5500

Starts

2011-10-01

Expected to finish

2027-12-31

Last updated by the study team

2026-05-13

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed histological diagnosis of solid tumor
• Suitable for systematic treatment and clinical trials
• ECOG (Eastern cooperative oncology group) performance status < 2
• Able to provide tumor tissue for molecular profiling
• Able to understand and sign the informed consent form

You may not qualify if…

• None

Where it is running

• National Cancer Centre, Singapore — Singapore, Singapore (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.